A carregar...

Prospective Study of Efficacy and Safety of Lansoprazole in Zollinger-Ellison Syndrome

Lansoprazole, a new substituted benzimidazole H(+),K(+)-ATPase inhibitor, profoundly inhibits gastric acid secretion and has potential use in the management of diseases such as Zollinger-Ellison syndrome (ZES). In the present study we evaluated the efficacy and safety of lansoprazole in controlling...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Dig Dis Sci
Main Authors: METZ, DAVID C., PISEGNA, JOSEPH R., RINGHAM, GARY L., FEIGENBAUM, KATHRYN, KOVIACK, PAMELA D., MATON, PAUL N., GARDNER, JERRY D., JENSEN, ROBERT T.
Formato: Artigo
Idioma:Inglês
Publicado em: 1993
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721849/
https://ncbi.nlm.nih.gov/pubmed/8425437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/bf01307541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!